CRNX - Crinetics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Annual
Subscribe to Premium to download historical data

Balance Sheet

All numbers in thousands
Breakdown
2019-12-31
2018-12-31
2017-12-31
2016-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
40,326
44,973
14,192
12,152
Other Short Term Investments
78,066
118,902
-
-
Total Cash
118,392
163,875
14,192
12,152
Other Current Assets
-
-
98
43
Total Current Assets
123,339
166,683
15,165
12,365
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
8,080
4,973
704
406
Accumulated Depreciation
-1,624
-741
-304
-182
Net property, plant and equipment
6,456
4,232
400
224
Other long-term assets
582
500
33
10
Total non-current assets
7,038
4,732
433
234
Total Assets
130,377
171,415
15,598
12,599
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
-
-
-
49
Accounts Payable
5,498
1,456
403
340
Accrued liabilities
-
3,809
179
229
Other Current Liabilities
724
-
-
-
Total Current Liabilities
8,340
7,925
897
890
Non-current liabilities
Long Term Debt
-
-
-
163
Total non-current liabilities
4,898
3,265
29,723
17,913
Total Liabilities
13,238
11,190
30,620
18,803
Stockholders' Equity
Common Stock
210,793
24
1
1
Retained Earnings
-93,802
-43,380
-16,265
-7,108
Accumulated other comprehensive income
148
61
-
-
Total stockholders' equity
117,139
160,225
-15,022
-6,204
Total liabilities and stockholders' equity
130,377
171,415
15,598
12,599